The U.S. Agency for International Development (USAID) has committed $2.3 million to purchase 4.8 million doses of malaria medication from Swiss Pharma (Swipha).
Trending
- Why WHO’s new malaria drug for newborns may not cut Nigeria deaths – Expert
- Why EFCC investigated Jerry Eze for alleged money laundering — Olukoyede
- FUTA don advocates people-centred engineering for sustainable industrial growth
- Nigeria bears highest sickle cell burden, experts warn
- Education, agriculture programmes free at UNILESA
- Senate approves Tinubu’s $516m loan request for Sokoto-Badagry Superhighway
- Ebonyi targets low-immunisation LGAs
- LG unveils smart dehumidifier for homes, hospitals
